Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 33
|
BSPED2013
|
Next issue
41st Meeting of the British Society for Paediatric Endocrinology and Diabetes
All volumes
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
Speaker Abstracts
CME TRAINING DAY
Bone physiology or calcium and phosphate metabolism
ea0033cme1
Vitamin D and rickets
ea0033cme2
Osteoporosis in children and young people
ea0033cme3
Normal and abnormal variations of growth and puberty: how can the new RCPCH specialist childhood and puberty close monitoring charts help us?
ea0033cme4
Puberty in SGA
ea0033cme5
Precocious puberty
ea0033cme6
MAIN SYMPOSIA
Early intervention on type 1 diabetes
ea0033pl1
Symposia 1 Care and controversies: present and future
Preservation of fertility
ea0033s1.1
Cancer treatment late effects on the endocrine system
ea0033s1.2
SAGhe: GH safety and long term concerns
ea0033s1.3
Symposia 2 Recent advances in CAH management
CaHASE: a UK collaborative study on CAH in adults
ea0033s2.1
Paediatric surveillance for CAH: informing newborn screening policy
ea0033s2.2
Symposia 3 Present and future: novelty and goals
Benefits of diabetes networks and beyond
ea0033s3.1
Screening for diabetes related complications
ea0033s3.2
What are the barriers of implementation to BPT
ea0033s3.3
Symposia 4 Debate: Pump vs MDI in all children with DMT1
Pump therapy in all newly diagnosed T1DM
ea0033s4.1
MDI in all newly diagnosed T1DM
ea0033s4.2
Diabetes Professionals Meeting Programme
NPD implications for practice
ea0033dp1
Implementation of structured education
ea0033dp2
Developing the role of diabetes educator in the UK
ea0033dp3
Psychology: narrative theory
ea0033dp4
Kids in control of food: results from the KICk-OFF randomised controlled trial
ea0033dp5
Transition to adult services
ea0033dp6
How does the The National Paediatric Diabetes Audit help improve outcomes for CYP with diabetes?
ea0033dp7
Endocrine Nurse Programme
Ipsen award 2012: managing children with symptomatic vitimin D deficiency; the role of the clinical nurse specialist
ea0033en1
The advanced nurse practitioner in paediatric endocrinology; the journey and the reality
ea0033en2
Multiple endocrine neoplasia (MEN) an overview
ea0033en3
Not another blood test! Parent/patient experience of MEN
ea0033en4
Oral Communications
Oral Communications 1
GH testing: reducing the need for a second test for the diagnosis of GH deficiency
ea0033oc1.1
A single centre audit of the 2012 UK Newborn Screening Programme Guidelines for pre-term infants
ea0033oc1.2
The utility of AMH for predicting testosterone response to HCG stimulation in children with suspected DSD
ea0033oc1.3
Abnormal glucose homeostasis in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation is associated with reduced [beta]-cell reserve and pancreatic volume
ea0033oc1.4
Novel genes affecting the timing of puberty
ea0033oc1.5
Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne muscular dystrophy
ea0033oc1.6
A mutation in thioredoxin reductase 2 is associated with familial glucocorticoid deficiency
ea0033oc1.7
The repressor activity of the Wnt/[beta]-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development
ea0033oc1.8
Genetic characterisation of short children with potential defects of GH action by single gene sequencing
ea0033oc1.9
Oral Communications 2
Whole Exome Sequencing as a diagnostic tool in adrenal insufficiency
ea0033oc2.1
Increased bone area without reduction in volumetric bone mineral density in children treated with glucocorticoids for nephrotic syndrome
ea0033oc2.2
Clinical phenotype of patients with MCM4 mutation suggests pubertal delay in males
ea0033oc2.3
FGF21 causes GH resistance in human chondrocytes through activation of SOCS2 and inhibition of IGF1 expression
ea0033oc2.4
Continuous s.c. infusion of parathyroid hormone reduces PTH requirement in patient with activating mutation of the calcium sensing receptor
ea0033oc2.5
Review of the clinical scoring systems in Silver-Russell syndrome and development of modified diagnostic criteria to guide molecular genetic testing
ea0033oc2.6
Novel lethal form of hypopituitarism associated with the first recessive LHX4 mutation
ea0033oc2.7
Establishing a national audit of paediatric GH prescribing
ea0033oc2.8
A comprehensive next generation sequencing-based strategy for genetic diagnosis in congenital hypothyroidism
ea0033oc2.9
A new approach to the definition and diagnosis of adrenal insufficiency during inhaled corticosteroid therapy for asthma
ea0033oc2.10
Oral Communications 3
Catch up growth and insulin sensitivity in adolescent children born preterm
ea0033oc3.1
GAD and IA2 autoantibody positivity is associated with a requirement for insulin treatment: results of the UK national paediatric Type 2 Diabetes cohort
ea0033oc3.2
Successful treatment of four patients with severe hyperinsulinaemic hypoglycaemia with a novel therapy using mTOR inhibitor
ea0033oc3.3
Successful Use of Long Acting Octreotide in Treatment of Congenital Hyperinsulinism
ea0033oc3.4
Loss of the tumour suppressor micro-RNA 34a, and anti tumour cellular immunity in paediatric obesity - is obesity increasing the future risk of cancer in children?
ea0033oc3.5
A feasibility study of intra-gastric balloons (supported by a lifestyle programme) for the treatment of severe adolescent obesity - the (BOB) Study.
ea0033oc3.6
Oral Communications 4
Risk factors for emergency hospital admission for diabetic ketoacidosis in children and young people: national cross-sectional analysis
ea0033oc4.1
Maturity-onset diabetes of young 5 (MODY5) with Gallbladder duplication cyst: a novel case
ea0033oc4.2
The incentive trial: do financial rewards improve glycaemic control in teenagers with poorly controlled type 1 diabetes?
ea0033oc4.3
Special features of neonatal diabetes in a series of Arab patients from the Gulf region
ea0033oc4.4
Peer Review: A tool to improve Paediatric Diabetes services
ea0033oc4.5
Increased urinary megalin and cubulin excretion in children with type 1 diabetes mellitus: an association with low molecular weight protein loss
ea0033oc4.6
Oral Communications 5
Joint BPSU-CAPSS Surveillance Study of Childhood Gender Identity Disorder
ea0033oc5.1
Clinical, biochemical and neuroradiological characterization of a cohort of patients with septo-optic dysplasia and multiple pituitary hormone deficiencies
ea0033oc5.2
Hypoglycaemia success during the insulin tolerance test: a two centre comparison
ea0033oc5.3
Poster Presentations
(1)
Plasma cortisol levels and adrenal weight in cases of death in childhood
ea0033p1
A descriptive analysis and prevalence of congenital adrenal hyperplasia in Sri Lankan children
ea0033p2
Diagnosing congenital adrenal hyperplasia. Radiologist rather than biochemist.
ea0033p3
Subnormal Synacthen testing in infants [lt]6 months age: a review of diagnoses and outcomes
ea0033p4
Primary glucocorticoid deficiency presenting as cholestatic jaundice in a neonate
ea0033p5
Severe 21-hydroxylase deficiency congenital adrenal hyperplasia and congenital hypothyroidism due to thyroglobulin mutations in a single family: two distinct genetic disorders with phenotypic variability within a single family
ea0033p6
Audit on the characteristics and management of patients in a large tertiary hospital paediatric adrenal clinic
ea0033p7
Reliability of diagnostic tests for paediatric Cushing's syndrome
ea0033p8
Enzyme-replacement therapy in life-threatening perinatal hypophosphatasia in a premature infant
ea0033p9
Case report: a novel PHEX mutation in a female with X-linked hypo-phosphataemic rickets
ea0033p10
Succesfully modified intermittent i.v. calcium treatment in a patient with hereditary vitamin D resistant rickets with alopecia: presence of nonsense mutation in ligand binding domain of vitamin D receptor
ea0033p11
Brown tumours caused by severe vitamin D deficiency: a report of two cases
ea0033p12
In unexplained hypoglycaemia, is the presence of ketones (betahydroxybutyrate) a reliable indicator that insulin is suppressed, excluding hyperinsulinism and avoiding the need to assay insulin directly
ea0033p13
Design and validation of a severity scale for use in congenital hyperinsulinism
ea0033p14
18F-DOPA PET MRI as a new imaging modality for the precise localisation of focal congenital hyperinsulinism
ea0033p15
Increasing weight in children with congenital hyperinsulinism is linked to KATP channel gene mutations
ea0033p16
Frequency of focal and diffuse congenital hyperinsulinism with paternally inherited mutations in ABCC8 and KCNJ11
ea0033p17
Altered plasma incretin concentrations in patients with non-typical forms of congenital hyperinsulinism
ea0033p18
6-Mercaptopurine linked with hyperinsulinaemic hypoglycaemia in two children with acute lymphoblastic leukaemia
ea0033p19
18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: Our experience of using oral sedation
ea0033p20
Long-term endocrine and exocrine outcome of medically unresponsive diffuse congenital hyperinsulinism managed with near-total pancreatectomy: 18 years' experience
ea0033p21
Evaluation of Postprandial Hyperinsulinaemic Hypoglycemia in Children
ea0033p22
Can we prevent hypoglycaemic brain injuries in term babies with no risk factors of Hyperinsulinaemic Hypoglycaemia?
ea0033p23
Normoammonaemic Protein Sensitive Hyperinsulinaemic Hypoglycaemia: ? A novel syndrome
ea0033p24
Gene expression profiling reveals possible role of growth factors in beta cell hyperplasia in congenital hyperinsulinism
ea0033p25
Screening for Coeliac disease in children diagnosed with diabetes mellitus
ea0033p26
Are paediatric patients attending their annual diabetic retinopathy screening?
ea0033p27
Resurgence of Lipoatrophy as a complication of treatment with insulin
ea0033p28
Prevalence and screening of thyroid and coeliac disease in type 1 diabetes mellitus
ea0033p29
GAD and IA2 autoantibody positivity is associated with a requirement for insulin treatment: results of the UK national paediatric type 2 diabetes cohort
ea0033p30
Growth and metabolic control in children and adolescents with type 1 diabetes mellitus associated with other autoimmune diseases
ea0033p31
Diabetes mellitus related to Williams syndrome: first report of childhood onset
ea0033p32
Transition of young people with diabetes: 3 years experience in a single centre
ea0033p33
Reduced acute complications, improved glycaemic control and reported quality of life in young diabetic patients on continuous s.c. insulin infusion (CSII)
ea0033p34
Tired, tachycardic, toxaemic, teenagers: fluids in severe DKA
ea0033p35
Insulin pumps for adolescents and young people; main problems observed in Macclesfield: United Kingdom
ea0033p36
Insulin pumps for adolescents and young people improve their quality of life
ea0033p37
Three Families with Diabetes Mellitus and Sensorineural Deafness
ea0033p38
Extreme hyperlipidaemia with poor glycaemic control in type 1 diabetes
ea0033p39
Sensor augmented insulin pump therapy in children with steroid induced diabetes (SID)
ea0033p40
How to manage steroid induced diabetes in children
ea0033p41
'A retrospective audit to observe the effect of the use of bolus calculators and carbohydrate counting have on blood glucose control in children and young people with type 1 diabetes'
ea0033p42
Challenges in Meeting Best Practice Guidelines at a District General Hospital in Yorkshire: a review of the changes that need to be made and the financial implications
ea0033p43
Mealtime insulin carbohydrate ratios and intensive insulin therapy
ea0033p44
Local factors influencing service improvements in median HbA1c in children and young people with diabetes between 2003 and 2012
ea0033p45
'Bridging The Gap': improving glycaemic control for children of African descent in London
ea0033p46
Factitious hypoglycaemia due to exogenous insulin 'Don't forget the skin'
ea0033p47
Development of a next generation sequencing panel for disorders of sex development (DSDs)
ea0033p48
Precious puberty in an infant is not normal
ea0033p49
Early puberty in two girls with Prader-Willi syndrome
ea0033p50
NR5A1 Mutation - A Rare Cause of Pubertal Androgenisation
ea0033p51
46,XX pure gonadal dysgenesis with tall stature due to an Xq21.2 deletion
ea0033p52
Rapid molecular genetic diagnosis aiding personalised treatment of 5-[alpha]; reductase type 2 deficiency
ea0033p53
Causes of precocious puberty in children referred to an Endocrine Unit in the Northwest of Turkey
ea0033p54
Diagnostic spectrum of female pubertal delay
ea0033p55
Review of the service for Turner syndrome patients at University Hospital of North Staffordshire
ea0033p56
Middle ear disease in Turner syndrome: prevalence and risk factors
ea0033p57
Exploring the culture of listening amongst children's nurses in an outpatient department: A mini-ethnographic study
ea0033p58
Screening log data can be used to inform protocol modifications, increasing patient recrutiment to a challanging clinical trial
ea0033p59
Dumping syndrome an often unrecognised problem following post nissen fundoplication, gastrostomy in infants
ea0033p60
Disease- and treatment-related factors implicated in late neuroendocrine morbidity after paediatric optic pathway gliomas: a multivariate analysis of 166 patients over 30 years
ea0033p61
Audit of obesity management in a tertiary endocrine centre
ea0033p62
Serial 'body composition' measurements will help resolve the continued weight gain dilemma in children with PWS
ea0033p63
Immune cell dysregulation - contributing to the risk of development of metabolic disease in childhood obesity
ea0033p64
Modulation of mesenchymal stem cell differentiation by alterations in GH action and cell-matrix interaction
ea0033p65
Chronic kidney disease: an uncommon cause of galactorrhoea in an adolescent
ea0033p66
Effect of latitude, summer daylight exposure and genetic background on growth response to recombinant human GH in GH deficient patients
ea0033p67
Multiple pituitary hormone deficiencies in two patients with arthrogryposis multiplex congenita
ea0033p68
Congenital nasal pyriform aperture stenosis and pituitary abnormalities: case series of 20 patients and a management guideline for early identification of pituitary insufficiency
ea0033p69
Growth hormone device change-over; is it beneficial?
ea0033p70
GH neurosecretory dysfunction may be associated with structural abnormalities of the hypothalamic-pituitary axis
ea0033p71
Assessment of cortisol and thyroid hormone levels in neonates with myelomeningocele
ea0033p72
Stopping desmopressin treatment in a child with hypopituitarism and epilepsy
ea0033p73
Comparison of Glucagon vs Clonidine stimulation test to diagnose growth hormone deficiency
ea0033p74
How late is too late to treat with Growth Hormone? A case study
ea0033p75
Abstract unavailable
ea0033p76
Urinary gonadotrophins: role in assessment and management of disorders of puberty
ea0033p77
How to improve the
ea0033p78
Use of prolactin concentrations in disorders of pituitary function and optic nerve hypoplasia
ea0033p79
Endocrine manifestations of CHARGE syndrome
ea0033p80
The role of GH in early postnatal life in mice
ea0033p81
The use of Radioactive Iodine in the treatment of childhood and adolescent hyperthyroidism
ea0033p82
BSPED National thyrotoxicosis study: patient characteristics and initial response to antithyroid drug therapy
ea0033p83
Incidence and clinical characteristics of dual thyroid ectopia in congenital hypothyroidism
ea0033p84
Kocher-Debre-Semelaigne syndrome: a report of three cases
ea0033p85
PTEN hamartoma syndrome: unravelling the complexities of childhood screening
ea0033p86
Review of presentation and management of juvenile thyrotoxicosis at a single-centre between 2000 and 2010
ea0033p87
An unexpected diagnosis of follicular-variant papillary thyroid carcinoma in an 11-year-old male
ea0033p88
Low remission rates and high failure rate for medical treatment of thyrotoxicosis in childhood and adolescence: strategic implications for stopping antithyroid drugs
ea0033p89